RECRUITING

Early Detection of Vaping-related Vascular Diseases

Talk to us

Conditions

VapingBlood Vessel Injury

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to determine how vaping affects blood vessels, in particular if early damage occurs in the lung vessels.

Official Title

Early Detection of Vaping-related Vascular Diseases

Quick Facts

Study Start:2022-09-12
Study Completion:2025-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05454267

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 40 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Current electronic cigarette (EC) Puff Bar users defined as using EC either daily or occasionally in the past 30 days for at least 6 months, and with 5% nicotine concentration pods.
  2. 2. Adults aged 18-40 years
  3. 1. Healthy never smokers, never vapers
  4. 2. Adults aged 18-40 years
  1. 1. Current or past smoking of tobacco cigarette (TC) or other tobacco/nicotine products (e.g., smokeless tobacco, Hookah) or marijuana will be excluded from the study.
  2. 2. Subjects with self-reported history of chronic health problems including asthma, chronic obstructive pulmonary disease (COPD), morbid obesity (BMI\>40 kg/m2), hypertension or diabetes
  3. 3. Pregnant or breastfeeding women

Contacts and Locations

Study Contact

Adam Wanner, MD
CONTACT
(305)243-2568
awanner@med.miami.edu
Michael Campos, MD
CONTACT
3052436388
mcampos1@med.miami.edu

Principal Investigator

Adam Wanner, MD
PRINCIPAL_INVESTIGATOR
University of Miami

Study Locations (Sites)

University of Miami Health System
Miami, Florida, 33136
United States

Collaborators and Investigators

Sponsor: University of Miami

  • Adam Wanner, MD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-12
Study Completion Date2025-06-30

Study Record Updates

Study Start Date2022-09-12
Study Completion Date2025-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Vaping
  • Blood Vessel Injury